Acquired equine motor neuron disease (AEMND) is a newly described disease in horse. AEMND is characterized by clinical symptoms of progressive weakness, weight loss, muscle fasiculations, muscle atrophy, and elevated serum creatine phosphokinase. These clinical symptoms coupled with the pathologic depiction of neural degenerative changes are very similar to those described in humans affected with sporadic amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease. Therefore, this study may be used as an animal model for ALS to obtain insight into the etiology, pathogenesis and biochemical mechanisms underlying the human disorders. Previous animal models failed to provide new information to understand ALS because they were either experimental models based on hypothesized etiologic factor or hereditary models that were based on hypotheses which the investigators failed to prove. However, AEMND in horses is advantageous to previous models due to the similarities in clinical signs and pathological lesions between the condition (AEMND) and ALS. We proposed this study to fully describe the distribution of the neurologic changes and determine the rate of occurrence of newly described acquired equine motor neuron disease (AEMND) in horses in the Northeast of the US. We also are planning to identify risk factors associated with this disease and quantifying their risk on the likelihood of developing AEMN. The epidemiologic study of choice is the ambidirectional design. This design, also referred to as nested case- control design, combines elements of cohort and case-control epidemiologic study designs. We will identify the horse population in the Northeast, US and follow them for 5 years. Suspected cases will be examined pathologically for confirmation and additional description of the neurodegenerative changes at New York State College of Veterinary Medicine (NYSCVM). The rate of occurrence of AEMND will then be determined. Noncases (controls) will also be selected from the horse population from which a AEMND case was identified. A comparison between cases and noncases with respect to the putative risk factors will then be made. These risk factors include intrinsic factors (age, sex, breed), health (disease history), management (husbandry, nutrition), and environmental factors (location, toxins, heavy metals, ...etc). Multivariate statistical techniques (logistic regression) will be used to identify risk factors significantly associated with the likelihood of developing AEMND while controlling simultaneously for other possible risk factors.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
First Independent Research Support & Transition (FIRST) Awards (R29)
Project #
5R29NS029674-04
Application #
2267800
Study Section
Epidemiology and Disease Control Subcommittee 2 (EDC)
Project Start
1992-04-01
Project End
1997-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
4
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Cornell University
Department
Other Clinical Sciences
Type
Schools of Veterinary Medicine
DUNS #
City
Ithaca
State
NY
Country
United States
Zip Code
14850
De la Rua-Domenech, R; Mohammed, H O; Cummings, J F et al. (1997) Association between plasma vitamin E concentration and the risk of equine motor neuron disease. Vet J 154:203-13
de la Rua-Domenech, R; Mohammed, H O; Cummings, J F et al. (1997) Intrinsic, management, and nutritional factors associated with equine motor neuron disease. J Am Vet Med Assoc 211:1261-7
de la Rua-Domenech, R; Wiedmann, M; Mohammed, H O et al. (1996) Equine motor neuron disease is not linked to Cu/Zn superoxide dismutase mutations: sequence analysis of the equine Cu/Zn superoxide dismutase cDNA. Gene 178:83-8
de la Rua-Domenech, R; Mohammed, H O; Cummings, J F et al. (1995) Incidence and risk factors of equine motor neuron disease: an ambidirectional study. Neuroepidemiology 14:54-64
de la Rua-Domenech, R; Mohammed, H O; Atwill, E R et al. (1995) Epidemiologic evidence for clustering of equine motor neuron disease in the United States. Am J Vet Res 56:1433-9
Mohammed, H O; Cummings, J F; Divers, T J et al. (1994) Epidemiology of equine motor neuron disease. Vet Res 25:275-8
Cummings, J F; de Lahunta, A; Summers, B A et al. (1993) Eosinophilic cytoplasmic inclusions in sporadic equine motor neuron disease: an electron microscopic study. Acta Neuropathol 85:291-7